Real-world efficacy of "fixed triple" single-inhaler combinations in COPD and asthma patients

被引：0
|
作者：
Mochizuki, Taichi [1 ]
Arai, Hiroyuki [1 ]
Inoue, Yasushi [1 ]
Ueda, Ryuta [1 ]
Nagase, Seisuke [1 ]
Umeda, Akira [2 ]
To, Yasuo [3 ]
Tsushima, Kenji [3 ]
机构：
[1] IUHW Int Univ Hlth & Welf, Resp Dis Ctr, Mita Hosp, Tokyo, Japan
[2] IUHW Shioya Hosp, Dept Resp Med, Yaita, Japan
[3] IUHW Narita Hosp, Dept Pulm Med, Narita, Japan
来源：
RESPIROLOGY | 2023年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
AP09-305
引用
收藏
页码：311 / 312
页数：2
相关论文
共 50 条
  • [21] Characteristics of COPD patients treated with single-inhaler triple therapy in real-life clinical practice
    Lassan, S.
    Keszegh, J.
    Lassanova, M.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2022, 123 (01): : 27 - 36
  • [22] ECONOMIC ANALYSIS OF NEW SINGLE-INHALER TRIPLE THERAPIES IN PATIENTS WITH COPD IN THE UK
    Cai, R.
    Martin, A.
    Ge, Y.
    Risebrough, N.
    Sharma, R.
    Haeussler, K.
    Compton, C.
    Halpin, D.
    Ismaila, A. S.
    VALUE IN HEALTH, 2022, 25 (12) : S183 - S184
  • [23] Reduced exacerbations following switch from multiple-inhaler to once-daily single-inhaler triple therapy in COPD patients in a real-world primary care setting in England
    Rothnie, K.
    Wood, R.
    Czira, A.
    Banks, V.
    Camidge, L.
    Massey, O.
    Seif, M.
    Compton, C.
    Sharma, R.
    Ismaila, A.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [24] Single-inhaler triple therapy in symptomatic COPD patients: FULFIL subgroup analyses
    Halpin, David M. G.
    Birk, Ruby
    Brealey, Noushin
    Criner, Gerard J.
    Dransfield, Mark T.
    Hilton, Emma
    Lomas, David A.
    Zhu, Chang-Qing
    Lipson, David A.
    ERJ OPEN RESEARCH, 2018, 4 (02)
  • [25] Comparative Effectiveness and Safety of Single-Inhaler Triple Therapy for COPD
    Feldman, William B.
    Suissa, Samy
    Kesselheim, Aaron
    Avorn, Jerry
    Russo, Massimiliano
    Schneeweiss, Sebastian
    Wang, Shirley V.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 683 - 684
  • [26] Benefit/Risk Profile of Single-Inhaler Triple Therapy in COPD
    Bourbeau, Jean
    Bafadhel, Mona
    Barnes, Neil C.
    Compton, Chris
    Di Boscio, Valentina
    Lipson, David A.
    Jones, Paul W.
    Martin, Neil
    Weiss, Gudrun
    Halpin, David M. G.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2021, 16 : 499 - 517
  • [27] First Real-World Evidence on High Dose Strength of Extrafine Single-Inhaler Triple Therapy in Asthma Patients after Three Months of Treatment TriMaximize Study
    Gessner, C.
    Bogoevska, V
    Nachtigall, D.
    Akyildiz, B.
    Martini, M.
    Wendt, A.
    Criee, C.
    PNEUMOLOGIE, 2024, 78 : S4 - S4
  • [28] Improvement of asthma control after 3 months of treatment with extrafine single-inhaler triple therapy in asthmatics: a real-world view from Germany
    Greulich, T.
    Akyildiz, B.
    Slawinska, R.
    Wendt, A.
    Bogoevska, V
    Gessner, C.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [29] Change in asthma control after 6 months of treatment with extrafine single-inhaler triple therapy in asthmatics: a real-world view from Germany
    Greulich, T.
    Akyildiz, B.
    Nachtigall, D.
    Bogoevska, V
    Gessner, C.
    PNEUMOLOGIE, 2023, 77 : S29 - S29
  • [30] Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study
    Strange, Charlie
    Tkacz, Joseph
    Schinkel, Jill
    Lewing, Benjamin
    Agatep, Barnabie
    Swisher, Sean
    Patel, Sushma
    Edwards, Devechio
    Touchette, Daniel R.
    Portillo, Edward
    Feigler, Norbert
    Pollack, Michael
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2023, 18 : 2245 - 2256
12345